₹ 1.1 Cr
Volume transacted
7.9 K
stocks traded
Last Updated time: 05 Nov 14:09 PM
Orchid Pharma Ltd
NSE: ORCHPHARMA
YEARHIGH
₹ 1591.55
Last updated on: Nov 04, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
04 Nov 2024 | 1394.75 | 1450.75 | 1456.7 | 1377.1 |
01 Nov 2024 | 1449.3 | 1473.6 | 1473.6 | 1428.5 |
31 Oct 2024 | 1456.2 | 1413.55 | 1461.25 | 1395.8 |
30 Oct 2024 | 1390.7 | 1265 | 1412.95 | 1265 |
29 Oct 2024 | 1309.25 | 1308.95 | 1325 | 1275.25 |
28 Oct 2024 | 1283.3 | 1261.5 | 1292 | 1240.8 |
25 Oct 2024 | 1255.45 | 1297.35 | 1331.6 | 1244.5 |
24 Oct 2024 | 1325.25 | 1272 | 1332.5 | 1272 |
23 Oct 2024 | 1280.85 | 1254 | 1319.15 | 1248.15 |
22 Oct 2024 | 1237.9 | 1288.15 | 1319.95 | 1223.2 |
Date | Price |
---|---|
04 Nov 2024 | 1394.75 |
01 Nov 2024 | 1449.3 |
31 Oct 2024 | 1456.2 |
30 Oct 2024 | 1390.7 |
29 Oct 2024 | 1309.25 |
28 Oct 2024 | 1283.3 |
25 Oct 2024 | 1255.45 |
24 Oct 2024 | 1325.25 |
23 Oct 2024 | 1280.85 |
22 Oct 2024 | 1237.9 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Orchid Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Orchid Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Orchid Pharma announces board meeting date
Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 20...
10 Aug 202412:49
Orchid Pharma to conduct AGM
Orchid Pharma announced that the Annual General Meeting (AGM) of the company will be held ...
18 Jul 202420:35
Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
Cefepime-Enmetazobactam has been approved for the treatment of complicated urinary tract i...
29 Jun 202410:08
Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
Orchid Pharma announced the launch of its new drug - Cefepime-Enmetazobactam, which has be...
28 Jun 202419:23
Orchid Pharma receives DCGI approval for Enmetazobactam
Orchid Pharma has received Drugs Controller General of India (DCGI) approval for the manuf...
06 Jun 202413:06
Orchid Pharma gains on DCGI nod for new antibiotic drug combination
DCGI has also granted permission to manufacture and market finished dosage form (FDF) of C...
06 Jun 202412:38
FAQs for 52 Week High of Orchid Pharma Ltd
What is the significance of Orchid Pharma Ltd reaching its 52-week high?
Why do investors monitor Orchid Pharma Ltd 52-week high?
Is Orchid Pharma Ltd a good buy when it hits its 52-week high?
What should I consider before investing in Orchid Pharma Ltd at its 52-week high?
Can Orchid Pharma Ltd stock price continue to rise after reaching its 52-week high?
Unlimited trading at just
Rs. 199*